Product References
Altered Membrane Expression and Function of CD11b Play a Role in the Immunosuppressive Effects of Morphine on Macrophages at the Nanomolar Level.
Pharmaceuticals (Basel, Switzerland)
Yu PC,Hao CY,Fan YZ,Liu D,Qiao YF,Yao JB,Li CZ,Yu Y
17-0479-42 was used in Flow cytometry/Cell sorting to find that morphine at 0.1-10 nM levels inhibited CD11b expression and function on macrophages via a µ-opioid receptor (MOR)-dependent mechanism, thereby reducing macrophage phagocytosis of tumor cells, a process that can be reversed by thymopentin (TP5), a commonly used immune-enhancing adjuvant in clinical practice.
Mon Feb 13 00:00:00 EST 2023
Altered Membrane Expression and Function of CD11b Play a Role in the Immunosuppressive Effects of Morphine on Macrophages at the Nanomolar Level.
Pharmaceuticals (Basel, Switzerland)
Yu PC,Hao CY,Fan YZ,Liu D,Qiao YF,Yao JB,Li CZ,Yu Y
17-0479-42 was used in Flow cytometry/Cell sorting to find that morphine at 0.1-10 nM levels inhibited CD11b expression and function on macrophages via a µ-opioid receptor (MOR)-dependent mechanism, thereby reducing macrophage phagocytosis of tumor cells, a process that can be reversed by thymopentin (TP5), a commonly used immune-enhancing adjuvant in clinical practice.
Mon Feb 13 00:00:00 EST 2023
Schweinfurthin induces ICD without ER stress and caspase activation.
Oncoimmunology
Zhang R,Neighbors JD,Schell TD,Hohl RJ
Published figure using CD47 monoclonal antibody (Product # 17-0479-42) in Flow Cytometry
Tue Aug 09 00:00:00 EDT 2022
Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy.
Theranostics
Zhou Y,Guo Y,Chen L,Zhang X,Wu W,Yang Z,Li X,Wang Y,Hu Z,Wang Z
17-0479-42 was used in Preparation of nanocapsules to develop a smart "Trojan horse" BBB-permeable nanocapsule termed "NAcp@CD47" to deliver anti-CD47 antibodies and stimulator of interferon genes (STING) agonists into GBM tissues in a stealth-like manner to reshaped the immune microenvironment by switching the phenotype of microglia and macrophages.
Tue Aug 02 00:00:00 EDT 2022
Anti-CD47 antibody synergizes with cisplatin against laryngeal cancer by enhancing phagocytic ability of macrophages.
Clinical and experimental immunology
Wang J,Zhang H,Yin X,Bian Y
Published figure using CD47 monoclonal antibody (Product # 17-0479-42) in Flow Cytometry
Wed Sep 01 00:00:00 EDT 2021
LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer.
Cell death & disease
Xu S,Wang X,Yang Y,Li Y,Wu S
17-0479-42 was used in Flow Cytometry to validate the increase in expression of LSD1 during the progression of cervical cancer and confirmed the enhanced therapeutic effect against cervical cancer when combining CD47/PD-L1 blockade therapy with an LSD1 inhibitor.
Wed Mar 17 00:00:00 EDT 2021
LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer.
Cell death & disease
Xu S,Wang X,Yang Y,Li Y,Wu S
17-0479-42 was used in Flow Cytometry to validate the increase in expression of LSD1 during the progression of cervical cancer and confirmed the enhanced therapeutic effect against cervical cancer when combining CD47/PD-L1 blockade therapy with an LSD1 inhibitor.
Wed Mar 17 00:00:00 EDT 2021
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer.
Life science alliance
McAndrews KM,Xiao F,Chronopoulos A,LeBleu VS,Kugeratski FG,Kalluri R
Published figure using CD47 monoclonal antibody (Product # 17-0479-42) in Flow Cytometry
Wed Sep 01 00:00:00 EDT 2021
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment.
Cell death & disease
Guillon J,Petit C,Moreau M,Toutain B,Henry C,Roché H,Bonichon-Lamichhane N,Salmon JP,Lemonnier J,Campone M,Verrièle V,Lelièvre E,Guette C,Coqueret O
17-0479-42 was used in Flow Cytometry to characterise the emergence of transformed tumour cells following chemotherapy-mediated senescence, and demonstrate that senescent cells favour tumour growth and metastasis, in vitro and in vivo.
Wed Feb 27 00:00:00 EST 2019
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment.
Cell death & disease
Guillon J,Petit C,Moreau M,Toutain B,Henry C,Roché H,Bonichon-Lamichhane N,Salmon JP,Lemonnier J,Campone M,Verrièle V,Lelièvre E,Guette C,Coqueret O
17-0479-42 was used in Flow Cytometry to characterise the emergence of transformed tumour cells following chemotherapy-mediated senescence, and demonstrate that senescent cells favour tumour growth and metastasis, in vitro and in vivo.
Wed Feb 27 00:00:00 EST 2019
Generation and testing of clinical-grade exosomes for pancreatic cancer.
JCI insight
Mendt M,Kamerkar S,Sugimoto H,McAndrews KM,Wu CC,Gagea M,Yang S,Blanko EVR,Peng Q,Ma X,Marszalek JR,Maitra A,Yee C,Rezvani K,Shpall E,LeBleu VS,Kalluri R
Published figure using CD47 monoclonal antibody (Product # 17-0479-42) in Flow Cytometry
Thu Apr 19 00:00:00 EDT 2018
Programmed cell removal by calreticulin in tissue homeostasis and cancer.
Nature communications
Feng M,Marjon KD,Zhu F,Weissman-Tsukamoto R,Levett A,Sullivan K,Kao KS,Markovic M,Bump PA,Jackson HM,Choi TS,Chen J,Banuelos AM,Liu J,Gip P,Cheng L,Wang D,Weissman IL
17-0479 was used in Flow cytometry/Cell sorting to show that unwanted cells such as ageing neutrophils and living cancer cells are susceptible to "labelling" by secreted calreticulin from macrophages, enabling their clearance through programmed cell removal.
Fri Aug 10 00:00:00 EDT 2018
Programmed cell removal by calreticulin in tissue homeostasis and cancer.
Nature communications
Feng M,Marjon KD,Zhu F,Weissman-Tsukamoto R,Levett A,Sullivan K,Kao KS,Markovic M,Bump PA,Jackson HM,Choi TS,Chen J,Banuelos AM,Liu J,Gip P,Cheng L,Wang D,Weissman IL
17-0479 was used in Flow cytometry/Cell sorting to show that unwanted cells such as ageing neutrophils and living cancer cells are susceptible to "labelling" by secreted calreticulin from macrophages, enabling their clearance through programmed cell removal.
Fri Aug 10 00:00:00 EDT 2018
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
Oncotarget
Liu R,Wei H,Gao P,Yu H,Wang K,Fu Z,Ju B,Zhao M,Dong S,Li Z,He Y,Huang Y,Yao Z
Published figure using CD47 monoclonal antibody (Product # 17-0479-42) in Flow Cytometry
Tue Jun 13 00:00:00 EDT 2017
Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy.
JCI insight
Yanagita T,Murata Y,Tanaka D,Motegi SI,Arai E,Daniwijaya EW,Hazama D,Washio K,Saito Y,Kotani T,Ohnishi H,Oldenborg PA,Garcia NV,Miyasaka M,Ishikawa O,Kanai Y,Komori T,Matozaki T
17-0479 was used in Functional assays to show that SIRPα is highly expressed in human renal cell carcinoma and melanoma, and that anti-SIRPα antibody blocks the interaction with CD47, suppressing tumor formation by renal cell carcinoma or melanoma cells.
Thu Jan 12 00:00:00 EST 2017
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer.
Nature communications
Betancur PA,Abraham BJ,Yiu YY,Willingham SB,Khameneh F,Zarnegar M,Kuo AH,McKenna K,Kojima Y,Leeper NJ,Ho P,Gip P,Swigut T,Sherwood RI,Clarke MF,Somlo G,Young RA,Weissman IL
17-0479 was used in Flow cytometry/Cell sorting to suggest that cancers can evolve SE to drive CD47 overexpression to escape immune surveillance.
Wed Apr 05 00:00:00 EDT 2017
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
Blood
Ho TC,LaMere M,Stevens BM,Ashton JM,Myers JR,O'Dwyer KM,Liesveld JL,Mendler JH,Guzman M,Morrissette JD,Zhao J,Wang ES,Wetzler M,Jordan CT,Becker MW
17-0479 was used in Flow cytometry/Cell sorting to provide a new frame of reference by which to evaluate candidate AML therapies in which both disease control and the induction of more advanced forms of disease should be considered.
Thu Sep 29 00:00:00 EDT 2016
Cells expressing the C/EBPbeta isoform, LIP, engulf their neighbors.
PloS one
Abreu M,Sealy L
17-0479 was used in Flow cytometry/Cell sorting to provide evidence that the transcription factor, LIP, induces cells to ingest other cells.
Thu Apr 11 00:00:00 EDT 2013